The benefit was seen in most individual components of the primary outcome, with a favorable trend, but driven mainly by significant reduction in acute decompensated heart failure (HR 0.27), stroke (HR 0.67), and acute coronary syndrome (HR 0.67).
← all excerpts
Cardiovascular disease in the literature: A selection of recent original research papers.
1
—
—